Literature DB >> 30700587

Cutting Edge: IL-27 Attenuates Autoimmune Neuroinflammation via Regulatory T Cell/Lag3-Dependent but IL-10-Independent Mechanisms In Vivo.

Dongkyun Kim1, Hongnga T Le1, Quang Tam Nguyen1, Sohee Kim1, Juyeun Lee1, Booki Min2.   

Abstract

IL-27 regulates immune responses in inflammation. The underlying mechanism of IL-27 functions has long been attributed to its ability to induce IL-10 production in activated CD4 T cells. In this study, we report that Foxp3+ regulatory T cells (Tregs) are the main target cells of IL-27, mediating its immunoregulatory functions in vivo. Systemically delivered IL-27 efficiently prevents the development of experimental autoimmune encephalomyelitis, an autoimmune inflammation in the CNS. However, it failed to do so upon Treg depletion. IL-27 signaling in Tregs was necessary, as transferring Tregs deficient in IL-27Rα or Lag3, a downstream molecule induced by IL-27, was unable to protect mice from experimental autoimmune encephalomyelitis. IL-27 efficiently induced IL-10 expression in CD4 T cells in vitro; however, we found no evidence supporting IL-27-induced IL-10 induction in CD4 T cells in vivo. Taken together, our results uncover an irreplaceable contribution of Tregs during IL-27-mediated control of inflammation.
Copyright © 2019 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30700587      PMCID: PMC6401226          DOI: 10.4049/jimmunol.1800898

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  Treg-specific IL-27Rα deletion uncovers a key role for IL-27 in Treg function to control autoimmunity.

Authors:  Jeongsu Do; Dongkyun Kim; Sohee Kim; Alice Valentin-Torres; Nina Dvorina; Eunjung Jang; Vivekananthan Nagarajavel; Tara M DeSilva; Xiaoxia Li; Angela H Ting; Dario A A Vignali; Stephen A Stohlman; William M Baldwin; Booki Min
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-05       Impact factor: 11.205

2.  Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells.

Authors:  Marcel Batten; Ji Li; Sothy Yi; Noelyn M Kljavin; Dimitry M Danilenko; Sophie Lucas; James Lee; Frederic J de Sauvage; Nico Ghilardi
Journal:  Nat Immunol       Date:  2006-08-13       Impact factor: 25.606

3.  Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice.

Authors:  Jeong M Kim; Jeffrey P Rasmussen; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2006-11-30       Impact factor: 25.606

Review 4.  Induction of regulatory Tr1 cells and inhibition of T(H)17 cells by IL-27.

Authors:  Caroline Pot; Lionel Apetoh; Amit Awasthi; Vijay K Kuchroo
Journal:  Semin Immunol       Date:  2011-09-03       Impact factor: 11.130

5.  Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells.

Authors:  Denise C Fitzgerald; Guang-Xian Zhang; Mohamed El-Behi; Zoë Fonseca-Kelly; Hongmei Li; Shuo Yu; Christiaan J M Saris; Bruno Gran; Bogoljub Ciric; Abdolmohamad Rostami
Journal:  Nat Immunol       Date:  2007-11-11       Impact factor: 25.606

6.  Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10.

Authors:  Jason S Stumhofer; Jonathan S Silver; Arian Laurence; Paige M Porrett; Tajie H Harris; Laurence A Turka; Matthias Ernst; Christiaan J M Saris; John J O'Shea; Christopher A Hunter
Journal:  Nat Immunol       Date:  2007-11-11       Impact factor: 25.606

7.  IL-27 blocks RORc expression to inhibit lineage commitment of Th17 cells.

Authors:  Caroline Diveu; Mandy J McGeachy; Katia Boniface; Jason S Stumhofer; Manjiri Sathe; Barbara Joyce-Shaikh; Yi Chen; Cristina M Tato; Terrill K McClanahan; René de Waal Malefyt; Christopher A Hunter; Daniel J Cua; Robert A Kastelein
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

8.  IL-27 gene therapy induces depletion of Tregs and enhances the efficacy of cancer immunotherapy.

Authors:  Jianmin Zhu; Jin-Qing Liu; Min Shi; Xinhua Cheng; Miao Ding; Jianchao C Zhang; Jonathan P Davis; Sanjay Varikuti; Abhay R Satoskar; Lanchun Lu; Xueliang Pan; Pan Zheng; Yang Liu; Xue-Feng Bai
Journal:  JCI Insight       Date:  2018-04-05

9.  An IL-27/Lag3 axis enhances Foxp3+ regulatory T cell-suppressive function and therapeutic efficacy.

Authors:  J-S Do; A Visperas; Y O Sanogo; J J Bechtel; N Dvorina; S Kim; E Jang; S A Stohlman; B Shen; R L Fairchild; W M Baldwin; D A A Vignali; B Min
Journal:  Mucosal Immunol       Date:  2015-05-27       Impact factor: 7.313

10.  IL-27-Induced Type 1 Regulatory T-Cells Produce Oxysterols that Constrain IL-10 Production.

Authors:  Solenne Vigne; Fanny Chalmin; Donovan Duc; Aurélie S Clottu; Lionel Apetoh; Jean-Marc A Lobaccaro; Isabelle Christen; Juan Zhang; Caroline Pot
Journal:  Front Immunol       Date:  2017-09-25       Impact factor: 7.561

View more
  11 in total

1.  Anti-inflammatory Roles of Glucocorticoids Are Mediated by Foxp3+ Regulatory T Cells via a miR-342-Dependent Mechanism.

Authors:  Dongkyun Kim; Quang Tam Nguyen; Juyeun Lee; Sung Hwan Lee; Allison Janocha; Sohee Kim; Hongnga T Le; Nina Dvorina; Kelly Weiss; Mark J Cameron; Kewal Asosingh; Serpil C Erzurum; William M Baldwin; Ju-Seog Lee; Booki Min
Journal:  Immunity       Date:  2020-07-23       Impact factor: 31.745

2.  Assessment of the Impact of Cytokines on TFH, TREG, and TFR Cell Populations After Influenza Infection.

Authors:  Amber Papillion; Meagan M Jenkins; André Ballesteros-Tato
Journal:  Methods Mol Biol       Date:  2022

Review 3.  Memory T Cells in Transplantation: Old Challenges Define New Directions.

Authors:  Michael Nicosia; Robert L Fairchild; Anna Valujskikh
Journal:  Transplantation       Date:  2020-10       Impact factor: 5.385

4.  Long-Term Effects of Alemtuzumab on CD4+ Lymphocytes in Multiple Sclerosis Patients: A 72-Month Follow-Up.

Authors:  Simona Rolla; Stefania Federica De Mercanti; Valentina Bardina; Alessandro Maglione; Daniela Taverna; Francesco Novelli; Eleonora Cocco; Anton Vladic; Mario Habek; Ivan Adamec; Pietro Osvaldo Luigi Annovazzi; Dana Horakova; Marinella Clerico
Journal:  Front Immunol       Date:  2022-02-28       Impact factor: 7.561

Review 5.  Exploring the role of interleukin-27 as a regulator of neuronal survival in central nervous system diseases.

Authors:  Andrea N Nortey; Kimberly N Garces; Abigail S Hackam
Journal:  Neural Regen Res       Date:  2022-10       Impact factor: 6.058

Review 6.  IL-30 (IL-27A): a familiar stranger in immunity, inflammation, and cancer.

Authors:  Booki Min; Dongkyun Kim; Matthias J Feige
Journal:  Exp Mol Med       Date:  2021-05-28       Impact factor: 12.153

7.  Interleukin 27 Protects From Gastric Atrophy and Metaplasia During Chronic Autoimmune Gastritis.

Authors:  Kevin A Bockerstett; Christine P Petersen; Christine N Noto; Lindsey M Kuehm; Chun Fung Wong; Eric L Ford; Ryan M Teague; Jason C Mills; James R Goldenring; Richard J DiPaolo
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2020-05-04

Review 8.  LAG-3: from molecular functions to clinical applications.

Authors:  Takumi Maruhashi; Daisuke Sugiura; Il-Mi Okazaki; Taku Okazaki
Journal:  J Immunother Cancer       Date:  2020-09       Impact factor: 13.751

9.  The IL-27 receptor regulates TIGIT on memory CD4+ T cells during sepsis.

Authors:  Kristen N Morrow; Zhe Liang; Ming Xue; Deena B Chihade; Yini Sun; Ching-Wen Chen; Craig M Coopersmith; Mandy L Ford
Journal:  iScience       Date:  2021-01-27

10.  Interleukin-27 Enforces Regulatory T Cell Functions to Prevent Graft-versus-Host Disease.

Authors:  Hongnga T Le; Karen Keslar; Quang Tam Nguyen; Bruce R Blazar; Betty K Hamilton; Booki Min
Journal:  Front Immunol       Date:  2020-02-12       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.